Infinity Pharmaceuticals, Inc filed a motion in the US Bankruptcy Court seeking the extension of its exclusivity periods on January 26, 2024. As per the motion, the debtor seeks to extend its exclusivity periods for both, to file a plan and to solicit votes on a plan, by 90 days i.e. up to April 29, 2024 and June 25, 2024, respectively. The debtor?s current exclusivity period and solicitation period would expire on January 29, 2024 and March 27, 2024, respectively.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.96% |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Mar. 25 | Infinity Pharmaceuticals, Inc. Went Out of Business | CI |
1st Jan change | Capi. | |
---|---|---|
-99.96% | 90 | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- INFI.Q Stock
- News Infinity Pharmaceuticals, Inc.
- First Motion for Exclusivity Period Extension Filed by Infinity Pharmaceuticals, Inc.